Stocks Alert: Johnson & Johnson (JNJ), The Blackstone Group L.P. (BX), Tesla, Inc. (TSLA)

Johnson & Johnson (JNJ) grew with the stock adding 0.75% or $0.88 to close at $118.08 on active trading volume of 7.11M compared its three months average trading volume of 6.78M. The New Brunswick New Jersey 08933 based company operating under the Drug Manufacturers – Major industry has been trending up for the last 52 weeks, with the shares price now 16.48% up for the period and up by 2.49% so far this year. With price target of $124.56 and a 19.45% rebound from 52-week low, Johnson & Johnson has plenty of upside potential, making it a hold with a view buy.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

The Blackstone Group L.P. (BX) dropped $-0.54 to close the day at a new closing price of $30.4, a -1.75% decrease in value from its previous closing price that moved the stock 41.69% above its 52 week low of $22.45. A total of 7.11M shares exchanged hands during the day compared with its three month average trading volume of 5.14M. The stock, which fluctuated between $30.33 and $31.15 during the day, currently situated -2.97% below its 52 week high. The stock is up by 4.35% in the past one month and up by 19.17% over the past three months. With a one year target estimate of $35.13 and RSI of 54.18, the stock still has upside potential, making it a hold for now.

The Blackstone Group L.P. is a publicly owned hedge fund sponsor. The firm also provides financial advisory services to its clients. It provides its services to public and corporate pension funds, academic, cultural, and charitable organizations, retirees, sovereign wealth funds, and institutional and individual investors. The firm manages separate client focused portfolios for its clients. It launches fixed income mutual funds. The firm also launches and manages private equity funds, real estate funds, funds of hedge funds, and credit-focused funds for its clients. It invests in private equity, public equity, fixed income, and alternative investment markets. The Blackstone Group L.P. was founded in 1985 and is based in New York, New York with additional offices in London, United Kingdom, Hong Kong, Beijing, China, Dubai, UAE, Dusseldorf, Germany, Los Angeles, Santa Monica, Mexico City, Mexico, Paris, France, Sao Paulo, Brazil, Seoul, Korea, Shanghai, China, Singapore, Sydney, Australia, Copenhagen, Denmark, and Tokyo, Japan.

Tesla, Inc. (TSLA) shares were down in last trading by -3.86% to $268.95. It experienced higher than average volume on day. The stock decreased in value by almost -0.09% over the past week and grew 12.83% in the past month. It is currently trading 16.49% above its 50 day moving average and 25.06% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -6.42% decrease in value from its one year high of $287.39. The RSI indicator value of 66.98, lead us to believe that it is a hold for now.

Tesla, Inc. designs, develops, manufactures, and sells electric vehicles and stationary energy storage products in the United States, China, Norway, and internationally. The company primarily offers sedans and sport utility vehicles. It also offers electric vehicle powertrain components and systems to other manufacturers. The company sells its products through a network of Tesla stores and galleries, as well as through Internet. In addition, it designs, manufactures, installs, monitors, maintains, leases, and sells solar energy systems to government, residential, and commercial customers; and sells electricity generated by solar energy systems to customers. The company was formerly known as Tesla Motors, Inc. and changed its name to Tesla, Inc. in February 2017. Tesla, Inc. was founded in 2003 and is headquartered in Palo Alto, California.

 

Trader Alert: Duke Energy Corporation (DUK), Aetna Inc. (AET), Johnson & Johnson (JNJ)

Duke Energy Corporation (DUK) retreated with the stock falling -0.83% or $-0.65 to close at $78.04 on active trading volume of 3.71M compared its three months average trading volume of 3.18M. The Charlotte North Carolina 28202 based company operating under the Electric Utilities industry has been trending up for the last 52 weeks, with the shares price now 5.61% up for the period and up by 0.54% so far this year. With price target of $79.72 and a 11.16% rebound from 52-week low, Duke Energy Corporation has plenty of upside potential, making it a hold with a view buy.

Duke Energy Corporation, together with its subsidiaries, operates as an energy company in the United States and Latin America. It operates through three segments: Regulated Utilities, International Energy, and Commercial Portfolio. The Regulated Utilities segment generates, transmits, distributes, and sells electricity in the Carolinas, Florida, Ohio, Kentucky, and Indiana; and transports and sells natural gas in southwestern Ohio and northern Kentucky. This segment owns approximately 50,000 megawatts (MW) of generation capacity; and uses coal, hydroelectric, natural gas, oil, and nuclear fuel to generate electricity. It serves approximately 7.4 million retail electric customers in 6 states in the Southeast and Midwest regions of the United States with a service area covering approximately 95,000 square miles; and approximately 525,000 retail natural gas customers in southwestern Ohio and northern Kentucky. This segment is also involved in the wholesale of electricity to incorporated municipalities, electric cooperative utilities, and other load-serving entities. The International Energy segment operates and manages power generation facilities; and markets and sells electric power, natural gas, and natural gas liquids. This segment serves retail distributors, electric utilities, independent power producers, marketers, and industrial and commercial companies. The Commercial Portfolio segment acquires, builds, develops, and operates wind and solar renewable generation and energy transmission projects. Its portfolio includes nonregulated renewable energy, electric transmission, natural gas infrastructure, and energy storage businesses. This segment has 22 wind farms and 38 commercial solar farms with a capacity of 2,400 MW across 11 states. The company was formerly known as Duke Energy Holding Corp. and changed its name to Duke Energy Corporation in April 2005. Duke Energy Corporation was incorporated in 2005 and is headquartered in Charlotte, North Carolina.

Aetna Inc. (AET) gained $3.76 to close the day at a new closing price of $125.81, a 3.08% increase in value from its previous closing price that moved the stock 27.39% above its 52 week low of $102.19. A total of 5.14M shares exchanged hands during the day compared with its three month average trading volume of 3.07M. The stock, which fluctuated between $121.6 and $126.87 during the day, currently situated -7.64% below its 52 week high. The stock is up by 2.86% in the past one month and up by 5.69% over the past three months. With a one year target estimate of $139.56 and RSI of 62.67, the stock still has upside potential, making it a hold for now.

Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management services, dental, behavioral health, and vision plans on an insured basis, as well as an employer-funded or administrative services contract basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers’ compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages retirement products, including pension and annuity products primarily for tax-qualified pension plans. The company offers its products to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. has a collaboration agreement with Commonwealth Health to introduce a new health plan; and Regional Cancer Care Associates to create an oncology medical home. The company was founded in 1853 and is based in Hartford, Connecticut.

Johnson & Johnson (JNJ) shares were up in last trading by 0.41% to $116.36. It experienced lighter than average volume on day. The stock increased in value by almost 2.54% over the past week and grew 1.54% in the past month. It is currently trading 1.81% above its 50 day moving average and 0.22% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -6.44% decrease in value from its one year high of $126.07. The RSI indicator value of 66.09, lead us to believe that it is a hold for now.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

 

Stocks Alert: Viacom, Inc. (VIAB), PayPal Holdings, Inc. (PYPL), Johnson & Johnson (JNJ)

Viacom, Inc. (VIAB) retreated with the stock falling -0.55% or $-0.24 to close at $43.65 on active trading volume of 6.26M compared its three months average trading volume of 4.09M. The New York New York 10036 based company operating under the Entertainment – Diversified industry has been trending up for the last 52 weeks, with the shares price now 39.63% up for the period and up by 24.36% so far this year. With price target of $42.83 and a 49.56% rebound from 52-week low, Viacom, Inc. has plenty of upside potential, making it a hold with a view buy.

Viacom, Inc. operates as media brand worldwide. The company creates television programs, motion pictures, short-form content, applications, games, consumer products, social media experiences, and other entertainment content for audiences. It operates through two segments, Media Networks and Filmed Entertainment. The Media Networks segment provides entertainment content and related branded products for consumers through approximately 250 locally programmed and operated TV channels, including Nickelodeon, Comedy Central, MTV, VH1, SPIKE, BET, CMT, TV Land, Nick at Nite, Nick Jr., Channel 5 (UK), Logo, Nicktoons, TeenNick, Paramount Channel, and others, as well as through online, mobile, and apps. The Filmed Entertainment segment produces, finances, acquires, and distributes motion pictures, television programming, and other entertainment content under the Paramount Pictures, Paramount Animation, Nickelodeon Movies, MTV Films, and Paramount Television brands; and distributes films released under the Paramount Vantage, Paramount Classics, and Insurge Pictures brands. This segment exhibits motion pictures theatrically through home entertainment, licensing to television and digital platforms, and ancillary activities. The company releases its content through download-to-own, download-to-rent, DVDs, Blu-ray discs, transactional video-on-demand, pay television, subscription video-on-demand, basic cable television, free television, and free video-on-demand, as well as airlines and hotels. Viacom, Inc. is headquartered in New York, New York.

PayPal Holdings, Inc. (PYPL) dropped $-0.25 to close the day at a new closing price of $40.58, a -0.61% decrease in value from its previous closing price that moved the stock 26.77% above its 52 week low of $34. A total of 6.25M shares exchanged hands during the day compared with its three month average trading volume of 7.16M. The stock, which fluctuated between $40.56 and $40.86 during the day, currently situated -8.85% below its 52 week high. The stock is down by -1.7% in the past one month and down by -1.65% over the past three months. With a one year target estimate of $46.83 and RSI of 51.66, the stock still has upside potential, making it a hold for now.

PayPal Holdings, Inc. operates as a technology platform company that enables digital and mobile payments on behalf of consumers and merchants worldwide. It enables businesses of various sizes to accept payments from merchant Websites, mobile devices, and applications, as well as at offline retail locations through a range of payment solutions, including PayPal, PayPal Credit, Braintree, Venmo, Xoom, and Paydiant products. The company’s platform allows consumers to shop by sending payments, withdraw funds to their bank accounts, and hold balances in their PayPal accounts in various currencies. PayPal Holdings, Inc. was founded in 1998 and is headquartered in San Jose, California.

Johnson & Johnson (JNJ) shares were up in last trading by 1.02% to $115.24. It experienced lighter than average volume on day. The stock increased in value by almost 1.41% over the past week and grew 0.44% in the past month. It is currently trading 0.96% above its 50 day moving average and -0.7% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -7.34% decrease in value from its one year high of $126.07. The RSI indicator value of 59.21, lead us to believe that it is a hold for now.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

 

Trader’s Round Up: Johnson & Johnson (JNJ), Chevron Corporation (CVX), National Oilwell Varco, Inc. (NOV)

Johnson & Johnson (JNJ) retreated with the stock falling -0.07% or $-0.08 to close at $113.4 on light trading volume of 5.27M compared its three months average trading volume of 7.22M. The New Brunswick New Jersey 08933 based company operating under the Drug Manufacturers – Major industry has been trending up for the last 52 weeks, with the shares price now 14.35% up for the period and down by -1.57% so far this year. With price target of $124.56 and a 16.63% rebound from 52-week low, Johnson & Johnson has plenty of upside potential, making it a hold with a view buy.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

Chevron Corporation (CVX) gained $0.19 to close the day at a new closing price of $111.58, a 0.17% increase in value from its previous closing price that moved the stock 44.53% above its 52 week low of $80.64. A total of 5.19M shares exchanged hands during the day compared with its three month average trading volume of 6.68M. The stock, which fluctuated between $110.32 and $111.79 during the day, currently situated -6.24% below its 52 week high. The stock is down by -3.68% in the past one month and up by 5.47% over the past three months. With a one year target estimate of $126.46 and RSI of 37.5, the stock still has upside potential, making it a hold for now.

Chevron Corporation, through its subsidiaries, engages in integrated energy, chemicals, and petroleum operations worldwide. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, and production of crude oil and natural gas; processing, liquefaction, transportation, and regasification associated with liquefied natural gas; transportation of crude oil through pipelines; and transportation, storage, and marketing of natural gas, as well as operates a gas-to-liquids plant. The Downstream segment engages in refining crude oil into petroleum products; marketing crude oil and refined products; transporting crude oil and refined products through pipeline, marine vessel, motor equipment, and rail car; and manufacturing and marketing commodity petrochemicals, and fuel and lubricant additives, as well as plastics for industrial uses. It is also involved in the cash management and debt financing activities; corporate administrative operations; insurance operations; real estate activities; and technology businesses. Further, the company holds interests in power plants, as well as operates geothermal plants; and engages in the transportation of refined products primarily in the coastal waters of the United States. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.

National Oilwell Varco, Inc. (NOV) shares were down in last trading by -0.2% to $39.21. It experienced higher than average volume on day. The stock increased in value by almost 1.71% over the past week and grew 2.99% in the past month. It is currently trading 2.21% above its 50 day moving average and 12.27% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -10.13% decrease in value from its one year high of $43.63. The RSI indicator value of 53.51, lead us to believe that it is a hold for now.

National Oilwell Varco, Inc. designs, manufactures, and sells equipment and components used in oil and gas drilling, completion, and production operations; and provides oilfield services to the upstream oil and gas industry worldwide. It operates through four segments: Rig Systems, Rig Aftermarket, Wellbore Technologies, and Completion & Production Solutions. The Rig Systems segment offers land rigs; offshore drilling equipment packages; and drilling rig components. This segment provides substructures, derricks, and masts; cranes; pipe lifting, racking, rotating, and assembly systems; fluid transfer technologies, such as mud pumps; pressure control equipment; power transmission systems; and rig instrumentation and control systems. The Rig Aftermarket segment offers spare parts; and repair and rental services, as well as technical support, field and first well support, field engineering, and customer training services. The Wellbore Technologies segment designs, manufactures, rents, and sells various equipment and technologies. This segment also provides solids control and waste management equipment and services, drilling fluids, power generation equipment, drill and wired pipes, instruments, measuring and monitoring equipment, downhole and fishing tools, hole openers, and drill bits, as well as drilling optimization and automation, tubular inspection, repair and coating, and rope access inspection services. The Completion and Production Solutions segment offers pressure pumping trucks and pumps, blenders, sanders, hydration units, injection units, flowlines, manifolds, and wellheads; well intervention tools; offshore production comprising composite pipes, process equipment, floating production systems, and subsea production technologies; and onshore production, including surface transfer and progressive cavity pumps, reciprocating pumps, pressure vessels, and artificial lift systems. The company was founded in 1862 and is headquartered in Houston, Texas.

 

Stocks in Focus: Annaly Capital Management, Inc. (NLY), International Paper Company (IP), Johnson & Johnson (JNJ)

Annaly Capital Management, Inc. (NLY) had a light trading with around 6.19M shares changing hands compared to its three month average trading volume of 7.14M. The stock traded between $10.31 and $10.4 before closing at the price of $10.4 with 0.87% change on the day. The New York New York 10036 based company is currently trading 22.51% above its 52 week low of $9.52 and -2.74% below its 52 week high of $11.29. Both the RSI indicator and target price of 64.85 and $10.35 respectively, lead us to believe that it should be put on hold over the coming weeks.

Annaly Capital Management, Inc. owns a portfolio of real estate related investments in the United States. It invests in various types of agency mortgage-backed securities and related derivatives to hedge these investments; and residential credit investments, such as credit risk transfer securities and non-agency mortgage-backed securities. The company also acquires, finances, and manages commercial loans and other commercial real estate debt, commercial mortgage-backed securities, and other commercial real estate-related assets. In addition, it engages in corporate middle market lending transactions; and operates as a broker-dealer. The company has elected to be taxed as a real estate investment trust (REIT). As a REIT, it is not subject to federal income tax to the extent that it distributes its taxable income to its shareholders. Annaly Capital Management, Inc. was founded in 1997 and is based in New York, New York.

International Paper Company (IP) continued its downward trend with the stock declining -2.66% or $-1.41 to close the day at $51.6 on active trading volume of 6.17M shares, compared to its three month average trading volume of 2.79M. The Memphis Tennessee 38197 based company has been outperforming the packaging & containers group over the past 52 weeks, with the stock gaining 54.05%, compared to the industry which has advanced 37.53% over the same period. With RSI of 35.81, the stock should still continue to rise and get closer to its one year target estimate of $56.2, making it a hold for now.

International Paper Company operates as a paper and packaging company in North America, Europe, Latin America, Russia, Asia, Africa, and the Middle East. The company operates through three segments: Industrial Packaging, Printing Papers, and Consumer Packaging. The Industrial Packaging segment manufactures containerboards, including linerboard, medium, whitetop, recycled linerboard, recycled medium, and saturating kraft. The Printing Papers segment produces printing and writing papers, such as uncoated papers for end use applications, including brochures, pamphlets, greeting cards, books, annual reports, and direct mail, as well as envelopes, tablets, business forms, and file folders. This segment sells uncoated papers under the Hammermill, Springhill, Williamsburg, Postmark, Accent, Great White, Chamex, Ballet, Rey, Pol, and Svetocopy brand names. It also produces pulp for manufacturing printing, writing, and specialty papers, as well as towels and tissues, filtration products, diapers, and sanitary napkins. The Consumer Packaging segment offers coated paperboards for various packaging and foodservice end uses, such as food, cosmetics, pharmaceuticals, and tobacco products under the Everest, Fortress, and Starcote brand names. This segment also produces cups, lids, food containers, and plates. The company sells its packaging products, paper products, and other products directly to end users and converters, as well as through agents, resellers, and paper distributors. International Paper Company was founded in 1898 and is headquartered in Memphis, Tennessee.

Johnson & Johnson (JNJ) shares were down in last trading by -0.21% to $113.4. It experienced lighter than average volume on day. The stock increased in value by almost 0.24% over the past week and fell -2.96% in the past month. It is currently trading -0.63% below its 50 day moving average and -2.25% below its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -8.82% decrease in value from its one year high of $126.07. The RSI indicator value of 48.13, lead us to believe that it is a hold for now.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

 

Stocks on the Move: Host Hotels & Resorts, Inc. (HST), NIKE, Inc. (NKE), Johnson & Johnson (JNJ)

Host Hotels & Resorts, Inc. (HST) managed to rebound with the stock climbing 0.22% or $0.04 to close the day at $17.91 on active trading volume of 7.88M shares, compared to its three month average trading volume of 10.88M. The Bethesda Maryland 20817 based company has been outperforming the reit – hotel/motel group over the past 52 weeks, with the stock gaining 38.31%, compared to the industry which has advanced 34.11% over the same period. With RSI of 44.14, the stock should still continue to rise and get closer to its one year target estimate of $18.18, making it a hold for now.

Host Hotels & Resorts, Inc. is a publicly owned real estate investment trust (REIT). The firm primarily engages in the ownership and operation of hotel properties. It invests in the real estate markets of United States. It also invests in Canada, Mexico, Chile, the United Kingdom, Italy, Spain, and Poland. The firm primarily invests in luxury and upper upscale hotels. It was formerly known as Host Marriott Corporation. Host Hotels & Resorts, Inc. was founded in 1927 and is based in Bethesda, Maryland.

NIKE, Inc. (NKE) fell -0.41% during last trading as the stock lost $-0.22 to finish the day at $52.8 with about 7.83M shares changing hands, compared to its three month average trading volume of 8.89M. The $87.36B market cap company, which fluctuated between $52.48 and $53.01 during the day, currently situated 8.12% above its 52 week low of $49.01 and -18.56% away from its one year high of $65.44. The RSI of 51.27 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

NIKE, Inc., together with its subsidiaries, designs, develops, markets, and sells athletic footwear, apparel, equipment, and accessories worldwide. It offers products in nine categories, including running, NIKE basketball, the Jordan brand, football, men’s training, women’s training, action sports, sportswear, and golf. The company also markets products designed for kids, as well as for other athletic and recreational uses, such as cricket, lacrosse, tennis, volleyball, wrestling, walking, and outdoor activities. In addition, it sells sports apparel; and markets apparel with licensed college and professional team and league logos. Further, the company sells a line of performance equipment, including bags, socks, sport balls, eyewear, timepieces, digital devices, bats, gloves, protective equipment, golf clubs, and other equipment under the NIKE brand name for sports activities; various plastic products to other manufacturers; athletic and casual footwear, apparel, and accessories under the Jumpman trademark; action sports and youth lifestyle apparel and accessories under the Hurley trademark; and casual sneakers, apparel, and accessories under the Converse, Chuck Taylor, All Star, One Star, Star Chevron, and Jack Purcell trademarks. Additionally, it licenses agreements that permit unaffiliated parties to manufacture and sell apparel, digital devices, and applications and other equipment for sports activities under NIKE-owned trademarks. The company sells its products to footwear stores, sporting goods stores, athletic specialty stores, department stores, skate, tennis and golf shops, and other retail accounts through NIKE-owned retail stores and Internet Websites (direct to consumer operations), as well as independent distributors and licensees. The company was formerly known as Blue Ribbon Sports, Inc. and changed its name to NIKE, Inc. in 1971. NIKE, Inc. was founded in 1964 and is headquartered in Beaverton, Oregon.

Johnson & Johnson (JNJ) saw its value increase by 0.3% as the stock gained $0.34 to finish the day at a closing price of $113.57. The stock was higher in trading and has fluctuated between $99.78-$126.07 per share for the past year. The shares, which traded within a range of $112.77 to $113.62 during the day, are down by -0.85% in the past three months and down by -7.09% over the past six months. It is currently trading -0.66% below its 20 day moving average and -0.54% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $125.06 a share over the next twelve months. The current relative strength index (RSI) reading is 48.9. The technical indicator lead us to believe there will be no major movement any time soon, hold.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

 

3 Stocks to Watch For: Xcel Energy Inc. (XEL), Honeywell International Inc. (HON), Johnson & Johnson (JNJ)

Xcel Energy Inc. (XEL) saw its value increase by 1.45% as the stock gained $0.59 to finish the day at a closing price of $41.32. The stock was higher in trading and has fluctuated between $36.25-$45.42 per share for the past year. The shares, which traded within a range of $40.75 to $41.34 during the day, are up by 2.42% in the past three months and down by -4.39% over the past six months. It is currently trading 1.29% above its 20 day moving average and 3.17% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $61.12 a share over the next twelve months. The current relative strength index (RSI) reading is 62.3.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Xcel Energy Inc., through its subsidiaries, engages primarily in the generation, purchase, transmission, distribution, and sale of electricity in the United States. It operates through Regulated Electric Utility, Regulated Natural Gas Utility, and All Other segments. The company generates electricity through coal, nuclear, natural gas, hydroelectric, solar, biomass, oil and refuse, and wind energy sources. It also purchases, transports, distributes, and sells natural gas. In addition, the company develops and leases natural gas pipelines, and storage and compression facilities; and invests in rental housing projects. It serves residential, commercial, and industrial customers in the portions of Colorado, Michigan, Minnesota, New Mexico, North Dakota, South Dakota, Texas, and Wisconsin. Xcel Energy Inc. was founded in 1909 and is based in Minneapolis, Minnesota.

Honeywell International Inc. (HON) shares were down in last trading by -0.66% to $118.32. It experienced higher than average volume on day. The stock increased in value by almost 0.31% over the past week and grew 2% in the past month. It is currently trading 1.93% above its 50 day moving average and 3.79% above its 200 day moving average. Following the recent decrease in price, the stock’s new closing price represents a -0.67% decrease in value from its one year high of $119.38. The RSI indicator value of 57.56, lead us to believe that it is a hold for now.

Honeywell International Inc. operates as a diversified technology and manufacturing company worldwide. Its Aerospace segment offers aircraft engines, integrated avionics, systems and service solutions, and related products and services for aircraft manufacturers and operators, airlines, military services, and defense and space contractors, as well as spare parts, and repair and maintenance services for the aftermarket. This segment also provides auxiliary power units; propulsion engines; environmental control, connectivity, electric power, flight safety, communication, navigation, radar, surveillance, and thermal systems; engine controls; aircraft lighting products, as well as wheels and brakes; advanced systems and instruments; and turbochargers, as well as management, technical, logistics, repair, and overhaul services to original equipment manufacturers in the air transport, regional, business, and general aviation aircraft; and automotive and truck manufacturers. The company’s Home and Building Technologies segment offers environmental and energy, security and fire, and building solutions. Its Safety and Productivity Solutions segment provides sensing and productivity Solutions, and industrial safety products. Its Performance Materials and Technologies segment provides catalysts and adsorbents; equipment and consulting services for the petroleum refining, gas processing, petrochemical, and other industries; and automation control, instrumentation, software, and services for the oil and gas, refining, pulp and paper, industrial power generation, chemicals and petrochemicals, biofuels, life sciences, metals, minerals, and mining industries. It also offers fluorocarbons, hydrofluoroolefins, caprolactam, resins, ammonium sulfate fertilizers, phenol, specialty films, waxes, additives, fibers, research chemicals and intermediates, and electronic materials and chemicals. The company was founded in 1920 and is based in Morris Plains, New Jersey.

Johnson & Johnson (JNJ) traded within a range of $112.43 to $113.4 after opening the day at $112.79. The company has seen its stock decrease in value by -1.7% so far this year. The stock was up close to 0.11% on active volume in last trading session and closed at $113.25 per share. After the recent gain, the stock is currently holding -8.94% below its 52 week high of $126.07 and 16.71% above its 12-month low of $99.78. The shares are down by over -1.12% in the last three months, and the RSI indicator value of 46.7 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

 

Trader’s Buzzers: Oracle Corporation (ORCL), Express Scripts Holding Company (ESRX), Johnson & Johnson (JNJ)

Oracle Corporation (ORCL) traded within a range of $40.13 to $40.39 after opening the day at $40.2. The company has seen its stock increase in value by 5.04% so far this year. The stock was up close to 0.25% on light volume in last trading session and closed at $40.23 per share. After the recent gain, the stock is currently holding -3.26% below its 52 week high of $42 and 18.49% above its 12-month low of $34.47. The shares are up by over 5.42% in the last three months, and the RSI indicator value of 62.75 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Oracle Corporation develops, manufactures, markets, sells, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide. It offers services in three primary layers of the cloud: Software as a Service, Platform as a Service, and Infrastructure as a Service. The company licenses its Oracle Database software, which enables storage, retrieval, and manipulation of various forms of data; and Oracle Fusion Middleware software to build, deploy, secure, access, and integrate business applications, as well as automate their business processes. It also provides a range of software for mobile computing to address the development needs of businesses; and Java, a software development language. In addition, the company offers application software, such as human capital and talent management, customer experience and customer relationship management, financial management and governance, risk and compliance, procurement, project portfolio management, supply chain management, business analytics and enterprise performance management, and industry-specific application software. Further, it offers hardware systems products, such as Oracle Engineered Systems, servers, storage, networking, industry specific hardware, virtualization software, operating systems, management software, and related hardware services. Additionally, the company offers customers with rights to software product upgrades and maintenance releases, patches released, and Internet access to technical content, as well as Internet and telephone access to technical support personnel. The company also provides consulting services, such as IT strategy alignment, enterprise architecture planning and design, initial product implementation and integration, and ongoing product enhancement and upgrade; customer support services; and education services. Oracle Corporation was founded in 1977 and is headquartered in Redwood City, California.

Express Scripts Holding Company (ESRX) continued its downward trend with the stock declining -2.35% or $-1.63 to close the day at $67.59 on active trading volume of 9.22M shares, compared to its three month average trading volume of 4.42M. The St. Louis Missouri 63121 based company has been underperforming the health care plans group over the past 52 weeks, with the stock losing -3.25%, compared to the industry which has advanced 16.65% over the same period. With RSI of 32.08, the stock should still continue to rise and get closer to its one year target estimate of $81.11, making it a hold for now.

Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States, Canada, and Europe. The company operates through two segments, PBM and Other Business Operations. The company’s PBM segment’s products and services include clinical solutions to enhance health outcomes; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary management; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services. In addition, the company distributes specialty pharmaceuticals and medical supplies to providers, clinics, and hospitals; and offers consulting services, including design, implementation, and project management for pharmaceutical, biotechnology, and device manufacturers to collect scientific evidence to guide the use of medicines. It serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2015, the company operated four automated dispensing home delivery pharmacies; one non-automated dispensing home delivery pharmacy; and one non-dispensing home delivery pharmacy maintained for business continuity purpose, as well as several non-dispensing order processing centers, patient contact centers, specialty drug pharmacies, and fertility pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.

Johnson & Johnson (JNJ) gained $1.54 to close the day at a new closing price of $113.38, a 1.38% increase in value from its previous closing price that moved the stock 16.84% above its 52 week low of $99.78. A total of 8.89M shares exchanged hands during the day compared with its three month average trading volume of 7.22M. The stock, which fluctuated between $111.9 and $113.54 during the day, currently situated -8.84% below its 52 week high. The stock is down by -2.18% in the past one month and down by -0.35% over the past three months. With a one year target estimate of $125.06 and RSI of 45.43, the stock still has upside potential, making it a hold for now.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

 

Stocks Roundup: Johnson & Johnson (JNJ), Visa Inc. (V), KeyCorp (KEY)

Johnson & Johnson (JNJ) grew with the stock adding 0.93% or $1.04 to close at $112.8 on active trading volume of 9.37M compared its three months average trading volume of 7.1M. The New Brunswick New Jersey 08933 based company operating under the Drug Manufacturers – Major industry has been trending up for the last 52 weeks, with the shares price now 14.64% up for the period and down by -2.09% so far this year. With price target of $125.05 and a 20.77% rebound from 52-week low, Johnson & Johnson has plenty of upside potential, making it a hold with a view buy.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

Visa Inc. (V) had a active trading with around 9.34M shares changing hands compared to its three month average trading volume of 10.33M. The stock traded between $83.45 and $84.27 before closing at the price of $83.9 with 0.8% change on the day. The San Francisco California 94128 based company is currently trading 27.86% above its 52 week low of $66.12 and 0.14% above its 52 week high of $84.27. Both the RSI indicator and target price of  and $94.55 respectively, lead us to believe that it could rise over the coming weeks.

Visa Inc. operates as a payments technology company worldwide. The company facilitates commerce through the transfer of value and information among consumers, merchants, financial institutions, businesses, strategic partners, and government entities. It operates VisaNet, a processing network that enables authorization, clearing, and settlement of payment transactions; and offers fraud protection for account holders and assured payment for merchants. The company also offers gateway services for merchants to accept, process, and reconcile payments; manage fraud; and safeguard payment security online, as well as processing services for participating issuers of visa debit, prepaid, and ATM payment products. In addition, it provides digital products, including Visa Checkout that offers consumers an expedited and secure payment experience for online transactions; and Visa Direct, a push payment product platform, which facilitates payer-initiated transactions that are sent directly to the Visa account of the recipient, as well as Visa token service that replaces the card account numbers from the transaction with a token. Further the company offers corporate (travel) and purchasing card products, as well as value-added services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company has a strategic partnership agreement with Oman Arab Bank to convert the bank’s current electron cards to chip-and-PIN debit cards. Visa Inc. was incorporated in 2007 and is headquartered in San Francisco, California.

KeyCorp (KEY) saw its value increase by 1.94% as the stock gained $0.35 to finish the day at a closing price of $18.4. The stock was lighter in trading and has fluctuated between $9.88-$18.77 per share for the past year. The shares, which traded within a range of $18.14 to $18.42 during the day, are up by 41.14% in the past three months and up by 60.43% over the past six months. It is currently trading 0.96% above its 20 day moving average and 3.17% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $19.65 a share over the next twelve months. The current relative strength index (RSI) reading is 54.93.The technical indicator lead us to believe there will be no major movement any time soon, hold.

KeyCorp operates as the bank holding company for KeyBank National Association that provides various retail and commercial banking services to individual, corporate, and institutional clients in the United States. The company’s Key Community Bank segment offers deposit and investment products; personal finance services and loans, including residential mortgages, home equity, credit cards, and various installment loans for individuals; deposits, investment and credit products, and business advisory services to small businesses; and financial, estate and retirement planning, and asset management services to high-net-worth clients. This segment also provides commercial lending, cash management, equipment leasing, investment and employee benefit programs, succession planning, access to capital markets, derivatives, and foreign exchange services to mid-sized businesses. Its Key Corporate Bank segment offers a suite of banking and capital market products, such as syndicated finance, debt and equity capital market products, commercial payments, equipment finance, commercial mortgage banking, derivatives, foreign exchange, financial advisory, and public finance, as well as commercial mortgage loans for middle market clients comprising consumer, energy, healthcare, industrial, public, real estate, and technology sectors. In addition, KeyCorp provides personal, securities lending, and custody services; access to mutual funds; treasury, investment banking, international banking, and investment management services; public retirement plans, and foundations and endowments plans; and financial services consisting of community development financing, securities underwriting, and brokerage, as well as merchant services. As of December 31, 2015, the company operated 966 retail banking branches and 1,257 automated teller machines in 12 states, as well as a telephone banking call center. KeyCorp was founded in 1849 and is headquartered in Cleveland, Ohio.

 

Trader’s Buzzers: Delcath Systems, Inc. (DCTH), Twitter, Inc. (TWTR), Johnson & Johnson (JNJ)

Delcath Systems, Inc. (DCTH) traded within a range of $0.308 to $0.49 after opening the day at $0.32. The company has seen its stock decrease in value by -48.16% so far this year. The stock was up close to 52.85% on active volume in last trading session and closed at $0.48 per share. After the recent gain, the stock is currently holding -99.57% below its 52 week high of $7.1984 and 58.91% above its 12-month low of $0.3001. The shares are down by over -79.44% in the last three months, and the RSI indicator value of 33.56 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Delivery System; and markets melphalan hydrochloride as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan in Europe. Its primary focus is on the execution of its clinical development program in ocular melanoma liver metastases, intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and certain other cancers that are metastatic to the liver. Delcath Systems, Inc. was founded in 1988 and is headquartered in New York, New York.

Twitter, Inc. (TWTR) failed to extend gains with the stock declining -0.54% or $-0.09 to close the day at $16.52 on light trading volume of 12.72M shares, compared to its three month average trading volume of 18.81M. The San Francisco California 94103 based company has been underperforming the internet information providers group over the past 52 weeks, with the stock losing -2.94%, compared to the industry which has advanced 19.44% over the same period. With RSI of 37.3, the stock should still continue to rise and get closer to its one year target estimate of $16.39, making it a hold for now.

Twitter, Inc. operates as a global platform for public self-expression and conversation in real time. The company offers various products and services, including Twitter that allows users to create, distribute, and discover content; and Periscope and Vine, a mobile application that enables user to broadcast and watch video live. It also provides promoted products and services, such as promoted tweets, promoted accounts, and promoted trends that enable its advertisers to promote their brands, products, and services; and subscription access to its data feed for data partners. In addition, the company offers a set of tools, public APIs, and embeddable widgets for developers to contribute their content to its platform; syndicate and distribute Twitter content across their properties; and enhance their Websites and applications with Twitter content. Twitter, Inc. was founded in 2006 and is headquartered in San Francisco, California.

Johnson & Johnson (JNJ) dropped $-2.15 to close the day at a new closing price of $111.76, a -1.89% decrease in value from its previous closing price that moved the stock 19.66% above its 52 week low of $99.78. A total of 12.43M shares exchanged hands during the day compared with its three month average trading volume of 7M. The stock, which fluctuated between $111.15 and $113.3 during the day, currently situated -10.14% below its 52 week high. The stock is down by -3.08% in the past one month and down by -0.8% over the past three months. With a one year target estimate of $125.05 and RSI of 30.13, the stock still has upside potential, making it a hold for now.

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates through three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON’S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women’s health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages under the BAND-AID brand name and first aid products under the NEOSPORIN brand name. This segment also provides over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases and vaccines, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic products; general surgery, biosurgical, endomechanical, and energy products; electrophysiology products to treat cardiovascular disease; sterilization and disinfection products to reduce surgical infection; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company offers its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use, as well as for use in the professional fields by physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.